COVID-19 antibody / Adaptive Biotech, Amgen - LARVOL DELTA

Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development. (PubMed, Front Immunol) - "We outline the currently available cellular immunity assays, review their readiness for use in clinical trials, their logistical requirements, and the type of information each assay generates. The objective is to provide a reliable source of information that could be leveraged to develop a rational approach for comprehensive immune monitoring during vaccine development."

Review • Infectious Disease • Novel Coronavirus Disease